Results 21 to 30 of about 40,297 (296)

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Neuropsychiatric Disease and Treatment, 2009
Paul Shotbolt1, Michael Samuel2,3, Chris Fox3,4, Anthony S David11Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King’s College, London, UK; 2Department of Neurology, King’s College hospital, London, UK; 3East Kent ...
Paul Shotbolt, Michael Samuel, Chris Fox, Anthony S David   +3 more
doaj   +1 more source

Systematic review on strength training in Parkinson’s disease: an unsolved question

Clinical Interventions in Aging, 2017
Ileana Ramazzina,1 Benedetta Bernazzoli,2 Cosimo Costantino1 1Department of Biomedical, Biotechnological and Translational Sciences, 2Department of Clinical and Experimental Medicine, Graduate School of Rehabilitation and Physical Medicine ...
Ramazzina I, Bernazzoli B, Costantino C
doaj   +1 more source

A Video Self-Modeling Intervention Using Virtual Reality Plus Physical Practice for Freezing of Gait in Parkinson Disease: Feasibility and Acceptability Study

JMIR Formative Research, 2021
BackgroundDespite optimal medical and surgical intervention, freezing of gait commonly occurs in people with Parkinson disease.
Lina Goh, Natalie E Allen, Naseem Ahmadpour, Kaylena A Ehgoetz Martens, Jooeun Song, Lindy Clemson, Simon J G Lewis, Hamish G MacDougall, Colleen G Canning   +8 more
doaj   +1 more source

Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. [PDF]

PLoS ONE, 2016
In the present study, we examined the potential symptomatic and/or disease-modifying effects of monthly bee venom injections compared to placebo in moderatly affected Parkinson disease patients.
Andreas Hartmann, Julia Müllner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck, Marie-Odile Habert, Aurélie Kas, Marie-Laure Tanguy, Merry Mazmanian, Hervé Oya, Nissen Abuaf, Hafida Gaouar, Sabrina Salhi, Fanny Charbonnier-Beaupel, Marie-Hélène Fievet, Damien Galanaud, Sophie Arguillere, Emmanuel Roze, Bertrand Degos, David Grabli, Lucette Lacomblez, Cécile Hubsch, Marie Vidailhet, Anne-Marie Bonnet, Jean-Christophe Corvol, Michael Schüpbach   +25 more
doaj   +1 more source

The Impact of a Digital Artificial Intelligence System on the Monitoring and Self-management of Nonmotor Symptoms in People With Parkinson Disease: Proposal for a Phase 1 Implementation Study

JMIR Research Protocols, 2022
BackgroundNonmotor symptoms of Parkinson disease are a major factor of disease burden but are often underreported in clinical appointments.
Edward Meinert, Madison Milne-Ives, K Ray Chaudhuri, Tracey Harding, John Whipps, Susan Whipps, Camille Carroll   +6 more
doaj   +1 more source

Refractory Seizures Secondary to Vitamin B6 Deficiency in Parkinson Disease: The Role of Carbidopa-Levodopa

Case Reports in Neurology, 2022
Carbidopa-levodopa has been used for more than 50 years in the treatment of Parkinson disease (PD) and other movement disorders. Pyridoxal 5′-phosphate (PLP), an active form of vitamin B6 (pyridoxine), is involved in the decarboxylation of levodopa to ...
Adina Wise, Hernan Nicolas Lemus, Madeline Fields, Matthew Swan, Susan Bressman   +4 more
doaj   +1 more source

Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)

BMC Neurology, 2021
Background Culminating evidence shows that current care does not optimally meet the needs of persons with parkinsonism, their carers and healthcare professionals.
Jan H. L. Ypinga, Angelika D. Van Halteren, Emily J. Henderson, Bastiaan R. Bloem, Agnes J. Smink, Emma Tenison, Marten Munneke, Yoav Ben-Shlomo, Sirwan K. L. Darweesh   +8 more
doaj   +1 more source

Parkinson's Syndrome Secondary to Congenital Absence of the Left Internal Carotid Artery: a Case Report and Review of the Literature [PDF]

Zhongguo quanke yixue, 2023
Congenital absence of the internal carotid artery (ICA) is a rare congenital developmental anomaly, which is often associated with carotid canal atresia and structural abnormalities of the ICA. It may be asymptomatic, or shows noticeable symptoms such as
SUN Xiaoling, LI Zhijun
doaj   +1 more source

Diurnal salivary cortisol concentrations in Parkinson’s disease: increased total secretion and morning cortisol concentrations

International Journal of General Medicine, 2011
Ö Skogar1,4, P-A Fall2, G Hallgren3, J Lökk4, B Bringer2, M Carlsson1, U Lennartsson3, H Sandbjork3, C-J Törnhage51Department of Geriatrics, Ryhov Hospital, Jonkoping, 2Department of Geriatrics, University Hospital, Linkoping ...
Skogar Ö, Fall P-A, Hallgren G, Lökk J, Bringer B, Carlsson M, Lennartsson U, Sandbjork H, Törnhage C-J   +8 more
doaj   +1 more source

Review on potential phytocompounds in drug development for Parkinson disease: A pharmacoinformatic approach

Informatics in Medicine Unlocked, 2016
Parkinson's disease (PD) is caused by human physiological function and is ranked as the second most common neurodegenerative disorder. One of the prominent therapies currently available for PD is the use of dopamine agonists which mimic the natural ...
S. Vijayakumar, S. Prabhu, S. Rajalakhsmi, P. Manogar   +3 more
doaj   +1 more source